Fig. 4
From: The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
Establishment of prognostic model based on m6A related lncRNAs in ML patients. (A) LASSO Cox regression was conducted to construct the prognostic model. (B) The ROC curves of the risk signature in training and testing group. (C, D) Multivariate and univariate Cox regression analyses of the associated between clinicopathological features (including risk score) and overall survival of patients in the training and testing group. **p < 0.01 and ***p < 0.001